Best of ASCO - 2014 Annual Meeting

 

Welcome

Quality of Care/Quality Improvement

Health Services Research, Clinical Informatics, and Quality of Care

2019 ASCO Annual Meeting

Sort by: title abstract no. first author
ABSTRACT TITLEFIRST AUTHORABSTRACT NO.
A digital oncology patient-reported outcomes platform: Building innovative electronic patient symptom assessments in epic mychart to improve the quality of life and survival of patients with advanced cancer.

Sidharth Anand

e18312

A physician-led team approach to improve advance directive completion rates in an inpatient oncology unit.

Manojna Konda

e18271

A population-based study of medical cannabis utilization in patients with cancer in the pre-legalization era.

Safiya Karim

e18297

A randomized study comparing physician-directed or fixed-dose dexamethasone replacement following incomplete steroid premedication for docetaxel chemotherapy.

Tina Hsu

6610

Adherence of oral targeted agents in patients with B-cell malignancies.

Laura S. Samples

e18301

Adherence to the guidelines: A comparison of biomarker testing implementation in metastatic non-squamous, non-small cell lung cancer in university versus community institutions.

Sufana Shikdar

6618

Analysis of a neurosurgical directed acute spinal cord compression pathway at Michigan Medicine, a tertiary referral hospital.

John C. Krauss

e18285

Anticancer therapy within the last 30 days of life: Results of an audit and re-audit cycle from a regional cancer center.

Mike Nguyen

e18260

Are the nonmedical needs of cancer patients satisfied adequately.

Monika Rucinska

e18283

Artificial intelligence-based clinical decision-support system improves cancer treatment and patient satisfaction.

Zuochao Wang

e18303

Assessment of contraception and fertility knowledge among female oncology patients of child bearing age and their providers.

Samantha Betman

e18270

Assessment of end-of-life care quality indicators in veterans with cancer.

Giselle Alexandra Suero-Abreu

e18327

Association of patient characteristics with real-world ROS1 NSCLC testing patterns among community practices in the United States.

William Bruce Wong

e18321

Central venous catheter-related complications in the treatment of cancer patients: A prospective study of over 124,000 catheter days.

Binliang Liu

e18264

Characterization of oncologic patient visits at the emergency department (ED) at an Austrian tertiary care center.

Christoph Minichsdorfer

6609

Clinical benefit of breakthrough cancer drugs approved by the United States Food and Drug Administration.

Consolacion Molto

6513

Combination of statin/vitamin D and metastatic castration-resistant prostate cancer (mCRPC): A post-hoc analysis of two randomized clinical trials.

Guillermo de Velasco

6617

Combined oral administration of analgesia and anxiolysis for pain associated with bone marrow aspiration and biopsy.

Claudio Cerchione

e18313

Comparison of normal saline versus heparin flush solutions for maintaining patency of central venous catheter in cancer patients.

Amy Pai

6501

Decreasing postoperative opioid prescriptions in ambulatory extended recovery patients.

Nkechi Fearon

6621

Delay in diagnosis and treatment of gastrointestinal cancer in Nepal.

Soniya Dulal

e18269

Design and implementation of outpatient-based rapid MRI protocols to rule out metastatic spinal cord compression and brain metastases.

Jessica G. Fried

e18307

Detection of the burnout syndrome, empathy, and psychosocial profile of the health team of the oncology service, UANL University Center Against Cancer (CUCC).

Adelina Alcorta-Garza

e18274

Does the innovative 4R Cancer Care Delivery Model improve patient self-management in safety net and non-safety net centers?

Julia Rachel Trosman

6601

Effect of montelukast and rupatadine on rituximab infusion time, rate, severity of reactions, and cost of administration.

Rouslan Kotchetkov

6500

Evaluating the challenges of cancer care in Botswana: Chemotherapy utilization and stock outs.

Sukhdeep Kaur

e18309

Evaluation of inpatient cancer rehabilitation by routine electronic patient-reported outcome measures (ePROM): Improvement of quality of life (QoL) and psychological distress.

Thomas Licht

e18294

Factors associated with physician attitude and management of financial toxicity.

Katrina Fischer

e18300

Feasibility of text-based symptom monitoring of ovarian and endometrial patients during treatment.

Michelle Joy Naughton

e18299

Giving voice to patients: Understanding treatment preferences of patients with multiple myeloma (MM).

Caroline McKay

e18302

Growth factor use and rate of neutropenic complications in breast cancer patients treated with dose-dense paclitaxel: A 5-year experience from a safety net hospital.

Racha Halawi

6527

Hypertension and use of bevacizumab among patients treated in community settings.

Heidi D. Klepin

e18279

Impact of an oncology urgent care clinic on emergency department rates.

Tannaz Sedghi

6615

Impact of cancer in pulmonary embolism presentation and outcomes: A large academic center study.

Cherry Au

6613

Impact of Electronically Accessible Pathways (EAPathways) on clinical trial enrollment at a large multisite cancer center.

Jeryl Jean Villadolid

6517

Impact of international collaboration utilizing E-consult and E-tumor board in the multidisciplinary management of cancer patients: A study from Mayo Clinic Care Network (MCCN) members.

Faraz A. Khan

e18261

Impact of Oncology Care Model (OCM) reporting requirements on quality of care.

Emily Castellanos

6620

Impact of sarcopenia for patients with localized muscle invasive bladder cancer treated by neoadjuvant cisplatin based chemotherapy and radical cystectomy.

Emilien Billon

e18286

Impact of specialist palliative care delivered over three months prior to death on a colorectal cancer patient’s risk of experiencing aggressive end-of-life care.

Aynharan Sinnarajah

6614

Impact of timing of lung resection on survival for clinical stage I and II lung cancer.

Isabel M Emmerick

6598

Implementation of ICH E6 (R2) through identification of data risks using analytics in oncology clinical trials.

Colin Hayward

e18319

Implementation of malignant bowel obstruction multidisciplinary case conferences (MCCs) to improve clinical decision making in malignant bowel obstruction (MBO) in gynecologic oncology.

Gita Bhat

e18322

Implementation of the Quality Training Program in Spain.

Rafael Lopez

e18296

Implementing physician education to increase lung cancer screening compliance.

Coral Olazagasti

e18282

Improving quality care through it/analytics for team-based care interventions.

Georgina T. Rodgers

e18263

Improving time to initiation of bone modifying agents in patients with newly diagnosed multiple myeloma.

Nathaniel Rosko

6528

Initial breast cancer consult: Improving satisfaction and impact on distress.

Veronica B. Decker

e18284

Integrating psychosocial care into routine cancer care: a stepped-wedge design cluster randomized controlled trial (SWD-RCT) to evaluate effectiveness of the HuCare Quality Improvement Strategy (HQIS) on health-related quality of life (HRQoL).

Rodolfo Passalacqua

6515

Interest and use of alternative/holistic therapies amongst cancer patients at a large urban safety-net hospital.

Bartlomiej Posnik

e18289

Knowledge, attitude and practice in cancer pain management: A survey study among attending physicians, residents and nurses.

Ying Ning

e18278

Laboratory and clinical data integration: Toward an evidence development framework.

Lori Anderson

e18318

Lack of clinician knowledge of human papillomavirus (HPV) vaccination to prevent HPV-related cancers in men: An interview study.

Stefan Varga

e18273

Medication-related osteonecrosis of the jaw: Evidence for infection versus oversuppression.

Kenneth Evan Fleisher

e18268

Metabolites as mediator for alleviating adverse effects in chemotherapy: A new finding from a recent study of Japanese traditional Kampo medicine, rikkunshito (RKT).

Hiroyuki Suzuki

e18292

Mortality within 30 days of immunotherapy (checkpoint inhibitors) in metastatic cancer patients treated at Australian tertiary cancer center.

Hiren A. Mandaliya

6600

Multi-institution quality improvement in supportive oncology: Results of the Coleman Supportive Oncology Collaborative (CSOC).

Paramjeet Khosla

6606

Muscle MASS and mortality in cancer patients.

Claudio Salas

e18290

Navigating care to reduce emergency room (ER) visits in cancer patients using opioids.

Carlos Frederico Pinto

e18265

NCI and ASCO CancerLinQ collaboration to advance quality of cancer care and surveillance.

Donna Rivera

e18317

Non-clinical needs of cancer patients in Spain under different perspectives: A comparative study.

Juan J. Cruz-Hernández

e18266

Online advertising and marketing claims by providers of proton beam therapy: Are they guideline based?

Mark Thomas Corkum

6599

Oral chemotherapy follow up on a Brazilian private health care unit.

Mauro Zukin

e18311

Patient satisfaction with oncology clinical decision support in South Korea.

Kyounga Lee

e18329

Patient-reported outcomes from two global multicenter clinical trials of children and adults with tropomyosin receptor kinase (TRK) fusion cancer receiving larotrectinib.

Shivaani Kummar

6602

Patients’ understanding and adherence to oral anti-cancer medication (OAM): Results of an institutional pilot study.

Angie Mae Rodday

e18280

Pneumocystis jiroveci pneumonia during first and second-line chemotherapy for solid tumours.

Emma Shaughnessy

e18330

Population-based cohort of prostate cancer patients on active surveillance (AS): guideline adherence, conversion to treatment and decisional regret.

Sabrina Peterson

6512

Practical exploration and research of Watson for oncology clinical decision support system in real-world and localized practice.

Zhonghe Yu

e18304

Practice variation on hospital level in the systemic treatment of metastatic colorectal cancer in the Netherlands: A population-based study.

Lotte Keikes

6612

Predictors of death for patients treated with palliative intent radiation using prospective databases.

Namita Agrawal

e18325

Preventing excess narcotic prescriptions in MIS urologic oncology discharges (PENN): A prospective cohort quality improvement initiative.

Ruchika Talwar

6502

QOL assessment integrated into the clinical care of cancer survivors to identify needs and direct care.

Christian S. Adonizio

6611

Qualifying sites for oncology clinical trials.

Dax Kurbegov

6619

Quality control system of Watson for oncology: Artificial intelligence for supporting clinical decisions in oncology.

Juemin Fang

6616

Quality of end-of-life care for veterans with metastatic cancer and advanced chronic kidney disease.

Shakira Jeanene Grant

e18281

Quality of life and tumor location in patients with desmoid tumors: Data from the desmoid tumor research foundation natural history study.

Kelly A Mercier

e18291

Quantifying febrile neutropenia rates using electronic medical records in a large integrated delivery network.

Holly Budlong

e18298

Randomized trial of text messaging (TM) to reduce early discontinuation of aromatase inhibitor (AI) therapy in women with breast cancer: SWOG S1105.

Dawn L. Hershman

6516

Review of the treatment milestones for stage I non-small cell lung cancer at a regional rural cancer center.

Antoine Joseph Harb

e18305

Should pregnancy testing during chemotherapy be standardized?

Natalie S Berger

e18314

Significance of examined lymph node number in accurate staging and long-term survival in resected stage I-II pancreatic cancer: More is better? A large international population-based cohort study.

Lei Huang

6503

Strategies for reducing grade 2 and 3 adverse events due to immunotherapy in a Spanish university hospital.

Ana Gomez

e18295

Survey to evaluate quality of cancer patient care: A questionnaire based analysis in a tertiary hospital.

Haritha Ackula

e18320

Survivorship care: Improving delivery of care plans for hematology patients at the Washington Cancer Institute (WCI).

Hira Latif

6605

Swallow screen and test in cancer patients.

Shiva Shrotriya

e18288

Symptoms and characteristics of cancer patient visits to an emergency room.

Michael Gallaway

e18306

The impact of NCI-sponsored network group clinical trials on guideline care and new drug indications.

Joseph M. Unger

6604

The impact of routine ESAS use on overall survival: Results of a population-based retrospective matched cohort analysis.

Lisa Catherine Barbera

6509

The practical ethics of medication shortages: Understanding patient preferences for allocation, decision making, and disclosure through narrative inquiry.

Andrew Hantel

e18323

The Quality Oncology Practice Initiative Program: Experience in Spain.

Rafael Lopez

e18267

The use of optimal evidence-based chemotherapy (chemo) regimens in physician offices versus hospital outpatient facilities.

Michael Jordan Fisch

6514

Understanding cancer care coordination: Opening the black box.

Maureen Canavan

e18310

Utilization of value stream mapping to improve chimeric antigen receptor (CAR) T-cell patient experience at an academic medical center (AMC).

Julie Porter

6607

Venous thromboembolism (VTE) in patients with ALK-rearranged non-small cell lung cancer (ALK-LC): A population-based cohort.

Alona Zer

6608

What do doctors value about attending multi-disciplinary cancer case discussions?

Paul Mitchell

e18324

Where’s my doctor? the impact of the primary oncologist’s visit with their hospitalized patients.

Brianna R. Bakow

6603